NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Formats Text Remove constraint Formats: Text Subjects Device Approval -- standards Remove constraint Subjects: Device Approval -- standards Genre Technical Report Remove constraint Genre: Technical Report

Search Results

1. FDA should further integrate its review of cybersecurity into the premarket review process for medical devices

2. Center for Devices and Radiological Health appeals processes: questions and answers about 517A : guidance for industry and Food and Drug Administration staff

3. Developing and responding to deficiencies in accordance with the least burdensome provisions: guidance for industry and Food and Drug Administration staff

4. Requests for feedback on medical device submissions: the pre-submission program and meetings with Food and Drug Administration staff : guidance for industry and Food and Drug Administration staff

5. Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff

6. Display devices for diagnostic radiology: guidance for industry and Food and Drug Administration staff

7. Deciding when to submit a 510(k) for a change to an existing device: guidance for Industry and Food and Drug Administration staff

8. Deciding when to submit a 510(k) for a software change to an existing device: guidance for industry and Food and Drug Administration staff

9. De novo classification process (evaluation of automatic class III designation): guidance for industry and Food and Drug Administration staff

10. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

11. FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors

14. Medical devices containing materials derived from animal sources (except for in vitro diagnostic devices): guidance for industry and Food and Drug Administration staff

15. Recommended content and format of non-clinical bench performance testing information in premarket submissions: guidance for industry and Food and Drug Administration staff

16. 30-Day notices, 135-day premarket approval (PMA) supplements and 75-day humanitarian device exemption (HDE) supplements for manufacturing method or process changes: guidance for industry and Food and Drug Administration staff

17. Requests for feedback and meetings for medical device submissions: the Q-Submission Program : guidance for industry and Food and Drug Administration staff

18. Utilizing animal studies to evaluate organ preservation devices: guidance for industry and Food and Drug Administration staff

19. Medical x-ray imaging devices conformance: guidance for industry and Food and Drug Administration staff

20. Laser products: conformance with IEC 60825-1 Ed. 3 and IEC 60601-2-22 Ed. 3.1 : (Laser Notice No. 56) : guidance for industry and Food and Drug Administration staff

21. Metal expandable biliary stents: premarket notification (510(k)) submissions : guidance for industry and Food and Drug Administration Staff

22. Consideration of uncertainty in making benefit-risk determinations in medical device premarket approvals, de novo classifications, and humanitarian device exemptions: guidance for industry and Food and Drug Administration staff